• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改变甘油三酯浓度会改变高甘油三酯血症患者的胰岛素-葡萄糖关系。吉非贝齐的双盲研究及其对动脉粥样硬化的影响。

Altering triglyceride concentrations changes insulin-glucose relationships in hypertriglyceridemic patients. Double-blind study with gemfibrozil with implications for atherosclerosis.

作者信息

Steiner G

机构信息

Division of Endocrinology and Metabolism, Toronto Hospital, Ontario, Canada.

出版信息

Diabetes Care. 1991 Nov;14(11):1077-81. doi: 10.2337/diacare.14.11.1077.

DOI:10.2337/diacare.14.11.1077
PMID:1797490
Abstract

OBJECTIVE

To determine whether reducing triglyceride concentrations in humans reduces serum insulin levels and consider the implications of this for the insulin resistance of hypertriglyceridemia.

RESEARCH DESIGN AND METHODS

Insulin and glucose levels were determined during an oral glucose tolerance test (OGTT) in 14 volunteers who had a range of basal triglyceride levels. A double-blind crossover design was used to study active and placebo gemfibrozil and relate triglyceride changes to insulin and glucose levels. Diet and weight were kept constant.

RESULTS

Glucose concentrations during OGTT were the same in both treatment periods. Insulin concentrations were reduced in proportion to reductions in triglyceride.

CONCLUSIONS

Triglyceride reduction in hypertriglyceridemic patients is associated with a decrease in serum insulin. This does not appear to be a direct effect of gemfibrozil, because it does not occur without a sufficient fall in triglyceride levels. Because glucose concentration remains the same despite the reduced insulin, the triglyceride reduction may result in greater sensitivity to insulin. Treatment of hypertriglyceridemia may break a vicious and potentially atherogenic cycle of hypertriglyceridemia and hyperinsulinemia.

摘要

目的

确定降低人体甘油三酯浓度是否会降低血清胰岛素水平,并探讨其对高甘油三酯血症胰岛素抵抗的影响。

研究设计与方法

在口服葡萄糖耐量试验(OGTT)期间,对14名基础甘油三酯水平各异的志愿者测定胰岛素和葡萄糖水平。采用双盲交叉设计研究活性吉非贝齐和安慰剂吉非贝齐,并将甘油三酯变化与胰岛素和葡萄糖水平相关联。饮食和体重保持恒定。

结果

两个治疗期OGTT期间的葡萄糖浓度相同。胰岛素浓度与甘油三酯的降低成比例降低。

结论

高甘油三酯血症患者甘油三酯的降低与血清胰岛素的降低有关。这似乎不是吉非贝齐的直接作用,因为没有足够的甘油三酯水平下降就不会发生这种情况。尽管胰岛素降低,但葡萄糖浓度保持不变,因此甘油三酯的降低可能导致对胰岛素的敏感性增加。高甘油三酯血症的治疗可能会打破高甘油三酯血症和高胰岛素血症的恶性循环以及潜在的致动脉粥样硬化循环。

相似文献

1
Altering triglyceride concentrations changes insulin-glucose relationships in hypertriglyceridemic patients. Double-blind study with gemfibrozil with implications for atherosclerosis.改变甘油三酯浓度会改变高甘油三酯血症患者的胰岛素-葡萄糖关系。吉非贝齐的双盲研究及其对动脉粥样硬化的影响。
Diabetes Care. 1991 Nov;14(11):1077-81. doi: 10.2337/diacare.14.11.1077.
2
Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia.
Metabolism. 1995 May;44(5):589-96. doi: 10.1016/0026-0495(95)90115-9.
3
Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients.
Atherosclerosis. 2000 Feb;148(2):397-406. doi: 10.1016/s0021-9150(99)00283-x.
4
Gemfibrozil treatment of endogenous hypertriglyceridemia: effect on insulin-mediated glucose disposal and plasma insulin concentrations.吉非贝齐治疗内源性高甘油三酯血症:对胰岛素介导的葡萄糖处置及血浆胰岛素浓度的影响。
J Clin Endocrinol Metab. 1996 Jul;81(7):2550-3. doi: 10.1210/jcem.81.7.8675576.
5
The effect of gemfibrozil on lipid profile and glucose metabolism in hypertriglyceridaemic well-controlled non-insulin-dependent diabetic patients. For the Gemfibrozil Study Group.吉非贝齐对高甘油三酯血症控制良好的非胰岛素依赖型糖尿病患者血脂谱和糖代谢的影响。为吉非贝齐研究组。
Acta Diabetol. 1999 Jun;36(1-2):27-33. doi: 10.1007/s005920050141.
6
Insulin action and glucose metabolism are improved by gemfibrozil treatment in hypertriglyceridemic patients.
Atherosclerosis. 1995 Feb;113(1):117-24. doi: 10.1016/0021-9150(94)05437-n.
7
Effects of gemfibrozil on insulin resistance to fat metabolism in subjects with type 2 diabetes and hypertriglyceridaemia.吉非贝齐对2型糖尿病合并高甘油三酯血症患者脂肪代谢胰岛素抵抗的影响。
Diabetes Obes Metab. 2002 May;4(3):187-94. doi: 10.1046/j.1463-1326.2002.00199.x.
8
Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM.吉非贝齐单独及与洛伐他汀联合治疗非胰岛素依赖型糖尿病患者的高甘油三酯血症。
Diabetes. 1989 Mar;38(3):364-72. doi: 10.2337/diab.38.3.364.
9
Gemfibrozil treatment of hypertriglyceridemia: improvement on fibrinolysis without change of insulin resistance.吉非贝齐治疗高甘油三酯血症:改善纤维蛋白溶解而不改变胰岛素抵抗。
Am Heart J. 1997 Sep;134(3):565-71. doi: 10.1016/s0002-8703(97)70096-6.
10
Gemfibrozil predictably lowers triglycerides but does not significantly change plasminogen activator inhibitor activity in hypertriglyceridemic patients with a history of thrombosis.
Thromb Res. 1991 Nov 15;64(4):493-501. doi: 10.1016/0049-3848(91)90349-2.

引用本文的文献

1
Cardiometabolic impact of non-statin lipid lowering therapies.非他汀类降脂治疗对代谢的影响。
Curr Atheroscler Rep. 2014 Feb;16(2):390. doi: 10.1007/s11883-013-0390-0.
2
Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review.非诺贝特:一种用于治疗脂质紊乱的新型制剂(力平之):综述
Int J Nanomedicine. 2006;1(2):129-47. doi: 10.2147/nano.2006.1.2.129.
3
Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis.厘清过氧化物酶体增殖物激活受体α在能量代谢和血管稳态中的作用。
J Clin Invest. 2006 Mar;116(3):571-80. doi: 10.1172/JCI27989.
4
Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome.用于治疗伴有胰岛素抵抗、糖尿病或代谢综合征的心血管疾病的脂质疗法。
Curr Cardiol Rep. 2005 Nov;7(6):457-64. doi: 10.1007/s11886-005-0064-9.
5
Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia.吉非贝齐。对其药理特性及在血脂异常管理中的地位的重新评估。
Drugs. 1996 Jun;51(6):982-1018. doi: 10.2165/00003495-199651060-00009.
6
Lowering of triglycerides by gemfibrozil affects neither the glucoregulatory nor antilipolytic effect of insulin in type 2 (non-insulin-dependent) diabetic patients.
Diabetologia. 1993 Feb;36(2):161-9. doi: 10.1007/BF00400699.
7
Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles.小而密低密度脂蛋白颗粒个体中的胰岛素抵抗和高胰岛素血症。
J Clin Invest. 1993 Jul;92(1):141-6. doi: 10.1172/JCI116541.
8
Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study.缺血性心脏病中的胰岛素:这些关联能由甘油三酯浓度来解释吗?卡菲利前瞻性研究。
Br Heart J. 1994 Mar;71(3):293-6. doi: 10.1136/hrt.71.3.293.
9
The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients.抗脂解剂(阿西莫司)对高甘油三酯血症患者脂质和葡萄糖代谢胰岛素抵抗的影响。
Acta Diabetol. 1994 Apr;31(1):6-13. doi: 10.1007/BF00580753.
10
Clinical relevance of reducing triglycerides. Implications for ischaemic heart disease treatment.降低甘油三酯的临床相关性。对缺血性心脏病治疗的影响。
Drugs. 1994 Jul;48(1):1-8. doi: 10.2165/00003495-199448010-00001.